10:06 AM EST - Microbix Biosystems Inc. : Provided an update on the conversion of its highest-selling product into bioreactors – that the largest customer for that antigen has confirmed its intended timetable for conversion of its future orders to bioreactor product and has provided its initial full-scale order. Microbix Biosystems Inc.
shares T.MBX are trading up $0.025 at $0.28.
